Mayo Clinic proceedings · 2026
Parity and Risk of Pancreatic Cancer Among Premenopausal Women: A Nationwide Cohort Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Park Joo-Hyun, Hong Jung Yong, Shen Jay J, Han Kyungdo, Park Joon Oh, Park Young Suk, Lim Ho Yeong
Аннотация
OBJECTIVE: To examine the association between parity and pancreatic cancer risk, along with other reproductive factors, in premenopausal women, amid the rising incidence of pancreatic cancer among younger women and concurrent decline in fertility rates.
PATIENTS AND METHODS: In this nationwide cohort study, 935,345 premenopausal women from 40 to 55 years of age without prior cancer who participated in the 2009 Korean National Cancer Screening Program were followed from January 1, 2009, through December 31, 2019, until pancreatic cancer diagnosis, death, or end of follow-up, whichever came first. Multivariable-adjusted HRs and 95% CIs were estimated using Cox proportional hazards regression models.
RESULTS: Over a median follow-up of 9.3 years, 2065 women developed pancreatic cancer (mean age at baseline, 45.0±3.9 years). The incidence rate was 30.2 per 100,000 person-years in nulliparous women, compared with 23.6 and 23.4 per 100,000 person-years in women with one and two or more births, respectively. Parity was inversely associated with pancreatic cancer risk, with adjusted HRs of 0.72 (95% CI, 0.57 to 0.91) for one birth and 0.70 (95% CI, 0.57 to 0.86) for two or more births, compared with nulliparity. The associations were consistent across most subgroups, except those stratified by alcohol consumption and hypertension (P for interaction =.001 and 0.02, respectively). Other reproductive factors were not significantly associated with risk.
CONCLUSION: Parity was associated with a reduced risk of pancreatic cancer in premenopausal women after adjustment for multiple potential confounders, suggesting that targeted prevention strategies for nulliparous women may help mitigate the growing burden of this malignancy among younger women.
PATIENTS AND METHODS: In this nationwide cohort study, 935,345 premenopausal women from 40 to 55 years of age without prior cancer who participated in the 2009 Korean National Cancer Screening Program were followed from January 1, 2009, through December 31, 2019, until pancreatic cancer diagnosis, death, or end of follow-up, whichever came first. Multivariable-adjusted HRs and 95% CIs were estimated using Cox proportional hazards regression models.
RESULTS: Over a median follow-up of 9.3 years, 2065 women developed pancreatic cancer (mean age at baseline, 45.0±3.9 years). The incidence rate was 30.2 per 100,000 person-years in nulliparous women, compared with 23.6 and 23.4 per 100,000 person-years in women with one and two or more births, respectively. Parity was inversely associated with pancreatic cancer risk, with adjusted HRs of 0.72 (95% CI, 0.57 to 0.91) for one birth and 0.70 (95% CI, 0.57 to 0.86) for two or more births, compared with nulliparity. The associations were consistent across most subgroups, except those stratified by alcohol consumption and hypertension (P for interaction =.001 and 0.02, respectively). Other reproductive factors were not significantly associated with risk.
CONCLUSION: Parity was associated with a reduced risk of pancreatic cancer in premenopausal women after adjustment for multiple potential confounders, suggesting that targeted prevention strategies for nulliparous women may help mitigate the growing burden of this malignancy among younger women.